NRC Health

As of June 30, 2026, NRC Health carries a market capitalization of 414.01M, placing it among publicly traded companies globally. Its enterprise value stands at 489.89M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

NRC Health's next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, NRC Health has 22.14M shares outstanding.

As of June 30, 2026, NRC Health trades at a trailing price-to-earnings ratio of 79.97. The price-to-sales ratio is 3.35, and the price-to-book ratio stands at 72.22.

As of June 30, 2026, NRC Health trades at an EV/EBITDA multiple of 23.95 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.00 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 37.98 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. NRC Health trades at an EV/FCF ratio of 22.37, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 489.89M versus a market cap of 414.01M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, NRC Health maintains a current ratio of 0.65, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,374.68, indicating moderate leverage, while an interest coverage ratio of 4.32 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, NRC Health posted a return on equity (ROE) of 42.03, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.26 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.22, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.29, useful for judging operating efficiency across full business cycles. The company generates approximately 340,623.69 in revenue per employee across its workforce of 359.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, NRC Health recorded 3.09M in income tax expense. That works out to an effective tax rate of 37.56, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 8.21M, leaving 5.13M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on September 24, 2026, NRC Health's stock has gained approximately 53.33% over the past 52 weeks. The 50-day moving average sits at 17.89, while the 200-day moving average is 15.84.

Over the twelve months ended June 30, 2026, NRC Health generated 122.54M in revenue and converted that into 5.13M in net income, yielding earnings per share of 0.23. EBITDA reached 20.45M, while operating income came in at 12.90M.

As of June 30, 2026, NRC Health holds 2.91M in cash and equivalents against 78.80M in total debt, resulting in a net debt position of 75.89M. Total book value stands at 5.73M, with working capital of -10.69M providing operational flexibility.

NRC Health produced 25.83M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.89M in capital expenditures, free cash flow totaled 18.94M - equivalent to 0.86 per share.

Over the twelve months ended June 30, 2026, NRC Health posted a gross margin of 61.75, reflecting its pricing power and cost economics. The operating margin of 10.53 and net profit margin of 4.19 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, NRC Health paid dividends of 0.51 per share. The dividend payout ratio of 216.85 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 4.61, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 4.99, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to NRC Health shareholders.

As of June 30, 2026, NRC Health has an Altman Z-Score of 4.25, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.